Price
CHART BY
Frequently asked questions
What is FRES SE&CNPV's market capitalization?
The market capitalization of FRES SE&CNPV is $30.63B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is FRES SE&CNPV's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for FRES SE&CNPV is 17.45. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for FRES SE&CNPV?
FRES SE&CNPV's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $3.117. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for FRES SE&CNPV's stock?
Currently, 15 analysts cover FRES SE&CNPV's stock, with a consensus target price of $64.26. Analyst ratings provide insights into the stock's expected performance.
What is FRES SE&CNPV's revenue over the trailing twelve months?
Over the trailing twelve months, FRES SE&CNPV reported a revenue of $27.00B.
What is the EBITDA for FRES SE&CNPV?
FRES SE&CNPV's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $3.89B. EBITDA measures the company's overall financial performance.
What is the free cash flow of FRES SE&CNPV?
FRES SE&CNPV has a free cash flow of $1.67B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does FRES SE&CNPV have, and what sector and industry does it belong to?
FRES SE&CNPV employs approximately 178,394 people. It operates in the Health Care sector, specifically within the Hospital/ Nursing Management industry.
What is the free float of FRES SE&CNPV's shares?
The free float of FRES SE&CNPV is 410.55M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $30.63B
- EPS (TTM)
- $3.117
- Free Float
- 410.55M
- P/E ratio (TTM)
- 17.45
- Revenue (TTM)
- $27.00B
- EBITDA (TTM)
- $3.89B
- Free Cashflow (TTM)
- $1.67B
Pricing
- 1D span
- $53.56$55.47
- 52W span
- $40.81$62.35
Analyst Ratings
The price target is $64.26 and the stock is covered by 15 analysts.
Buy
14
Hold
1
Sell
0
Information
Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. It operates through the Fresenius Kabi and Fresenius Helios segments. The Fresenius Kabi segment specializes in lifesaving medicines and technologies. The Fresenius Helios offers expertise in inpatient and outpatient care as well as in telemedicine. The company was founded by Eduard Fresenius on October 1, 1912 and is headquartered in Bad Homburg, Germany.
- Employees
- 178,394
- Industries
- Hospital/ Nursing Management
- Sector
- Health Care
Identifier
- ISIN
- DE000FRE5EN2
- Primary Ticker
- FRE
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet